Overview
- 9 inspections across 9 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-07-22.
At a glance
Inspections
9
Sites
9
Observations
0
Career since
Mar 2022
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Catalent Pharma Solutions, LLC | 22 Jul 2025 | Human Drugs | On file |
| Bio-Thera Solutions, Ltd. | 17 Jan 2025 | Human Drugs | On file |
| BTGEN Co., Ltd. | 25 Jun 2024 | Human Drugs | On file |
| AGC Biologics, Inc. | 27 Mar 2024 | Human Drugs | On file |
| Intas Pharmaceuticals Limited | 7 Dec 2023 | Human Drugs | On file |
Sites inspected
Catalent Pharma Solutions, LLCMadison, United States1 insp.
Bio-Thera Solutions, Ltd.Guangzhou, China1 insp.
BTGEN Co., Ltd.Yeonsu, Korea (the Republic of)1 insp.
AGC Biologics, Inc.Bothell, United States1 insp.
Intas Pharmaceuticals LimitedMoraiya, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Thuy T Nguyen5 shared
Jiangsong Jiang2 shared
Yiwei Li2 shared
Michael Shanks1 shared
Hyung-Yul Lee1 shared
Aditi Thakur1 shared
Jose M Cayuela1 shared
Yasamin Ameri1 shared
Full investigator report
Get the verbatim findings behind Jeanne M Fringer's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site